Know Cancer

or
forgot password

Diagnostic Transluminal Endoscopic Peritoneoscopy


Phase 0
18 Years
80 Years
Not Enrolling
Both
Pancreatic Cancer

Thank you

Trial Information

Diagnostic Transluminal Endoscopic Peritoneoscopy


We propose to investigate the efficacy of transgastric endoscopic peritoneoscopy with
endoscopic biopsy in patients undergoing diagnostic laparoscopy and who will require a
concurrent gastrotomy for placement of a PEG, gastrojejunostomy or gastric resection.

We hypothesize that diagnostic endoscopic peritoneoscopy can be done safely with adequate
visualization of the abdominal cavity to direct clinical treatment.


Inclusion Criteria:



- Pancreatic Cancer undergoing staging laparoscopy

- Staging or diagnostic laparoscopy in anyone needing enteral access

Exclusion Criteria:

- Lack of consent

- Intra-abdominal adhesions precluding diagnostic laparoscopy

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic

Outcome Measure:

1) That transgastric endoscopic peritoneoscopy is feasible.

Outcome Time Frame:

4/12

Safety Issue:

Yes

Principal Investigator

Jeffrey W Hazey, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Ohio State University

Authority:

United States: Institutional Review Board

Study ID:

2006H0120

NCT ID:

NCT00427752

Start Date:

October 2006

Completion Date:

January 2012

Related Keywords:

  • Pancreatic Cancer
  • Transgastric
  • Endoluminal
  • Peritoneoscopy
  • Diagnostic
  • Feasibility
  • Pancreatic Neoplasms

Name

Location

The Ohio State University Center for Minimally Invasive SurgeryColumbus, Ohio  43210